In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of ...
Dermatology in the near future will be characterized by digitally enabled, patient-centred research that reaches people where ...
AI is rapidly entering clinical care, but malpractice law has not kept pace. As adoption accelerates, clinicians are being ...
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), a precision guided biotech/life sciences company focused on advancing ...
Recently, the U.S. Food and Drug Administration (FDA) issued a guidance document entitled Use of Real-World Evidence to Support ...
The U.S. Food and Drug Administration (FDA) has rebuked the founder of Moose Jaw’s controversial Dr. Goodenowe Restorative ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that our ...
A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
Systemic inflammation has been elevated to a modifiable cardiovascular risk factor requiring assessment, monitoring, and modification, based on consensus recommendations.
SHANGHAI, SHANGHAI, CHINA, January 26, 2026 /EINPresswire.com/ -- Communication across linguistic boundaries has become ...
Detailed price information for Adia Nutrition Inc (ADIA) from The Globe and Mail including charting and trades.